This paper serves to provide an update W4GF Advocates on the Global Fund allocation methodology for the 2020-2022 funding cycle. It also seeks to highlight key recommendations from W4GF as the Global Fund continues to refine its allocation methodology.
In 2017, the Global Fund contracted APMG Health to conduct assessments of the design, implementation, and monitoring of national HIV service packages for KP in 65 countries, across six regions in which the Global Fund has provided HIV grant funds. This report is a global-level analysis of those assessments.
Publisher: O’Neill Institute for National & Global Health Law
The Global Fund to Fight AIDS, Tuberculosis and Malaria has proven highly effective at fighting the world’s major killers. Strong governance and development institutions, however, are necessary for improving health long-term. While some suggest international aid can strengthen institutions, others worry “dead” aid undermines governance. The Fund is a unique aid institution with mechanisms designed to improve transparency and accountability. We constructed a unique dataset to explore whether Global Fund financing has a significant effect on governance and development.
Several GFAN Speakers participated in the Preparatory Meeting for the Global Fund’s Sixth Replenishment in India earlier this month. The participating Speakers: Maurine Murenga , Timur Abdullaev , Resty Nalwanga , and Erika Castellanos all had different roles during the meeting. With Timur speaking on a panel on sustainable financing for health, Erika speaking to attendees about mobilizing communities and young people to end the epidemics and achieve Sustainable Development Goals, and both Maurine and Erika participating as part of their roles as Board Member and Alternate Board Member for the Communities Delegation to the Global Fund. Finally, Resty addressed the Global Fund Board and guests to share her story and to highlight the importance of the Global Fund.
Resty was kind enough to share with us her speech.
On 11 January 2019 the Global Fund released a summary of their Investment Case which will be released in full in the next few weeks. We shared our concern with the numbers presented and that the $US14 billion funding target set for the Global Fund’s Sixth Replenishment will not be enough. This target is significantly lower than the need calculated in our Get Back On Track Report published in July 2018 in which we made a strong case for significant increases in funding to the Global Fund with a replenishment target of US$16.8 to 18 billion.
Matthew Kavanagh (HealthGap US and Georgetown U Visiting Professor & Director, Global Health Policy & Governance Initiative at the O’Neill Institute for National and Global Health Law) published the thread below and his analysis echoed some of our concerns with the US$ 14 billion ask.
We worked with Matt to delve into the details and source the data:
GFAN Statement on the Global Fund Investment Case Announcement
GFAN and its members welcome the Global Fund’s Investment Case summary released today in France by President Macron for its clear articulation that we are not yet on track to reach the targets of ending the three diseases by 2030 and that we must significantly step up our response to get back on track.
We are however concerned that the $US14 billion funding target set for the Global Fund’s Sixth Replenishment will not be enough to achieve this vital task. This target is significantly lower than the need calculated in our Get Back On Track Report published in July 2018 in which we made a strong case for significant increases in funding to the Global Fund with a replenishment target of US$16.8 to 18 billion.
We remain concerned that with foreign exchange fluctuations and changes in pricing, that this is barely more than a m...